Last update:
Oncology news
Rethinking radiotherapy may boost immunotherapy for pancreatic cancer
Pancreatic cancer remains one of the most aggressive malignancies, with a particularly poor prognosis even when diagnosed at a localized stage. In a paper published in Nature Reviews Gastroenterology & Hepatology, researchers ...
23 hours ago
0
8
People affected by cancer need a stronger voice in shaping generative AI for oncology, review finds
Flinders University researchers were part of an international team that conducted a scoping review that identified 2,441 records and found that just 32 studies examined how cancer patients, survivors and caregivers feel about ...
19 hours ago
0
4
AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain
Artificial intelligence may help radiologists identify subtle signs of breast cancers that are missed during routine mammograms, and some AI systems may even identify patterns associated with an increased risk of cancer before ...
Sep 4, 2026
0
19
Tumor biology could guide mantle cell lymphoma treatment from the time of diagnosis
Today, treatment decisions for patients with mantle cell lymphoma are heavily based on age alone, although the disease can range from slow-growing (indolent) to very aggressive. In a new journal article, Ingrid Glimelius ...
Sep 4, 2026
0
2
FDA approves first-in-class drug for polycythemia vera
The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.
Sep 4, 2026
0
7
Cancer cells release antioxidants to prevent immune cells from destroying them
Molecules called reactive oxygen species, which include so-called "free radicals," have long been viewed as damaging byproducts of our body's metabolism—a reason antioxidant supplements have been considered a potential way ...
Sep 3, 2026
0
194
Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical models
In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated ...
Sep 3, 2026
0
73
Microdroplets may reduce colorectal tumor growth at potentially lower cost
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth ...
Sep 3, 2026
0
5
Patients diagnosed with lung cancer found to have more microplastic in their lungs
People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to research that will be presented at the European Respiratory Society ...
Sep 3, 2026
0
7
Hydrogel-grown tumors could speed cancer drug testing, reduce animal use
A review by University of Manchester scientists says sophisticated lab-grown tumors could help fast-track the search for new cancer treatments while reducing reliance on animal testing.
Sep 3, 2026
0
5
Study uncovers why some immunotherapy-treated tumors may grow faster
A new Northwestern Medicine study has uncovered a biological mechanism that may explain why a subset of tumors unexpectedly grows at an accelerated rate after being treated with certain immunotherapies, according to findings ...
Sep 3, 2026
0
5
AI skin cancer detection tools are getting better, but only for people with light skin
Imagine you're getting out of the shower one morning and notice a mole on your thigh that you've never seen before. It's reddish-brown, bumpy and surprisingly large. Is it a benign mole, or is it melanoma?
Sep 3, 2026
0
2
Caregivers of children with cancer engage in culinary medicine classes and coaching in new study
Caregivers play an essential role in helping children maintain adequate nutrition during their cancer treatment. But treatment-related side effects, such as nausea and poor appetite, can make feeding a child particularly ...
Sep 3, 2026
0
2
Family cancer burden predicts risk in patients with inflammatory bowel disease
People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely to develop the disease themselves. This is demonstrated by a new Swedish registry study from ...
Sep 3, 2026
0
4
Alcohol-linked cancer's toll extends far beyond the liver, with deaths rising across age groups
A Global Burden of Disease analysis estimated that the annual number of alcohol-attributable cancer deaths in the U.S. increased from 11,361 in 1990 to 23,126 in 2023. The study also revealed that alcohol-linked cancer deaths ...
Sep 2, 2026
0
188
Healthier fats linked to longer survival after prostate cancer diagnosis
Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, cardiovascular disease and other cancers remain important threats to their long-term health. For ...
Sep 2, 2026
0
78
Powerful new tool reveals potential 'goldmine' of cancer targets hidden in 'junk DNA'
A QIMR Berghofer-led team has developed a powerful tool to explore and understand the mysterious workings of the vast region of the human genome once dismissed as "junk DNA," discovering thousands of molecules that could ...
Sep 2, 2026
0
12
Genetic pathway offers new insight into timing of early brain development
Melbourne researchers have uncovered a critical signaling pathway that controls the timing of brain development, shedding new light on how neurodevelopmental disorders may develop. The research, led by Murdoch Children's ...
Sep 2, 2026
0
7
Less-intensive drug combination is more effective in treating acute myeloid leukemia, clinical trial finds
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice ...
Sep 2, 2026
0
5
Pre-surgery immunotherapy may improve treatment for deadly brain cancer
With a five-year survival rate of barely 5%, glioblastoma remains one of the deadliest brain cancers. First-line treatment consists of surgery to remove as much tumor tissue as possible.
Sep 2, 2026
0
5
Daraxonrasib demonstrates initial antitumor activity in RAS-mutant lung cancer
Daraxonrasib, an oral RAS inhibitor therapy, achieved durable responses in pretreated patients with RAS-mutant non-small cell lung cancer (NSCLC) in a phase 1/2 trial led by The University of Texas MD Anderson Cancer Center.
Sep 2, 2026
0
7
Novel spatial technology may improve our understanding of cancer biology
Northwestern Medicine scientists have developed a novel high-resolution spatial genomics platform that may enhance future research into how genome organization and genetic alterations contribute to disease development, including ...
Sep 2, 2026
0
5
Mini-tumors reveal new drug combinations for liver cancer
Liver cancer is difficult to treat because tumors vary greatly from patient to patient. Researchers at the University of Basel have captured this diversity by creating a collection of mini-tumors, which they use to systematically ...
Sep 2, 2026
0
4
New class of KRAS inhibitors shows promise in shrinking NF1 nerve tumors
A scientist at Cincinnati Children's who has hunted for decades for ways to shrink the painful and disfiguring nerve tumors caused by neurofibromatosis type 1 (NF1) has made a new breakthrough in the quest. Nancy Ratner, ...
Sep 2, 2026
0
5
Small spaces and stiffness may help cancer cells escape and spread
A new biomaterial developed by researchers from The University of Western Australia is providing fresh insights into the way cancer cells escape from tumors and spread through the body.
Sep 2, 2026
0
4
